POMC and cardiac hypertrophy: The relative number of Pomc+ cells increased consistently in all major cell types during the early stage of cardiac hypertrophy (2 weeks after TAC) and then declined during the development of heart failure (5–8 weeks after TAC) (Fig. 1E).